Home

Shukra Pharmaceuticals Ltd EPS

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

EPS

₹ 0.19

Last updated on: Apr 02, 2025

Key Highlights

  • The Earning per Share of Shukra Pharmaceuticals Ltd is ₹ 0.19 as of 02 Apr 25 .
  • The earning per share of Shukra Pharmaceuticals Ltd changed from ₹ 0.59 to ₹ 0.72 over 7 quarters. This represents a CAGR of 12.05% .

Historical Earning per Share of Shukra Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Shukra Pharmaceuticals Ltd

Market Cap

919 Cr

EPS

0.2

P/E Ratio (TTM)

110.5

P/B Ratio (TTM)

16.9

Day’s High

20.58

Day’s Low

20.58

DTE

0.1

ROE

26.6

52 Week High

27.15

52 Week Low

5.75

ROCE

29.3

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Apr 202521
01 Apr 202521.42
28 Mar 202521.85
27 Mar 202522.25
26 Mar 202522.7
25 Mar 202523.15
24 Mar 202523.6
21 Mar 202524.05
20 Mar 202523.6
19 Mar 202524.08

SWOT Analysis Of Shukra Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Shukra Pharmaceuticals Ltd

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

920

Asset Value

Value addition

15.4 X

56

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Shukra Pharmaceuticals Ltd919.55
Sun Pharmaceutical Industries Ltd411306
Divis Laboratories Ltd150343
Cipla Ltd117323
Torrent Pharmaceuticals Ltd108614
Mankind Pharma Ltd99891

Historical Market Cap of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Shukra Pharmaceuticals Ltd News Hub

Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as

Read more

13 Aug 24

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 202

Read more

05 Aug 24

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company will be h

Read more

16 Sept 24

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 September

Read more

24 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Shukra Pharmaceuticals Ltd

What is the EPS of Shukra Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Shukra Pharmaceuticals Ltd is 0.19. An EPS is the amount of net income attributed to each share of a common stock.

How is Shukra Pharmaceuticals Ltd EPS calculated?

The EPS of Shukra Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Shukra Pharmaceuticals Ltd report its EPS?

Shukra Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Shukra Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Shukra Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Shukra Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Shukra Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions